
Journal Menu
► Journal MenuJournal Browser
► Journal BrowserSpecial Issue "Natural Coumarins as Lead Compounds and Their Synthetic Analogues with Biological Activities"
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: 30 November 2023 | Viewed by 4920
Special Issue Editors
Interests: medicinal chemistry; heterocyclic compounds; design and synthesis; anticancer activity; antimicrobial activity; structure-activity relationship
Interests: medicinal chemistry; nitrogen-containing heterocyclic compounds; Cu(II) complexes; design and synthesis; anticancer activity; structure-activity relationship
Special Issue Information
Dear Colleagues,
Coumarins belong to a large family of extensively studied compounds containing the 2H-1-benzopyran-2-one core structure. They are widely distributed in the natural kingdom and occur as secondary metabolites in the seeds, flowers, fruits, leaves, roots, and stems of various plant species used as spices, herbal teas, or medicines. In addition to plant sources, coumarins are also present in some bacteria and fungi, as well as marine organisms. The history of coumarins can be traced back to 1820, when H. A. Vogel first isolated the simplest member of this family—coumarin from the plant Coumarouna odorata Aubl. (syn. Dipteryx odorata (Aubl.) Forsyth f.). Regarding their chemical structures, natural coumarins can be divided into different groups, from simple coumarins and bis-coumarins to several other types of polycyclic coumarins, such as furanocoumarins, pyranocoumarins, benzocoumarins, and coumestans. These naturally derived compounds exhibit a broad spectrum of biological properties, including anticoagulant, anti-inflammatory, antioxidant, antimicrobial (antibacterial, antiviral, antifungal, and antiparasitic), antitumor, neuroprotective, antidiabetic, and enzyme inhibitory effects. Their multi-faceted pharmacological activities along with their high bioavailability, low toxicity, and minor side effects make them attractive lead compounds for the development of novel therapeutic agents. Many strategies have been developed for the synthesis and modification of coumarin structural scaffolds, providing the possibility of designing new coumarin-based compounds as potential drug candidates against various diseases. Coumarins have also been investigated as supramolecular medicinal agents, diagnostic and pathological probes, and biological stains.
In this Special Issue, original research and review articles on the role of natural coumarins as important phytochemicals and lead compounds in drug research, their applications, as well as the development of their synthetic analogues, are highly welcome.
Dr. Anita Kornicka
Dr. Łukasz Balewski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- coumarin
- coumarin derivatives
- natural products
- synthesis
- biological activity
- drug discovery
- drug candidates